Orthocell Limited (OCC.AX)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Paul Frederick Anderson | CEO, MD & Executive Director | 650.97k | -- | 1966 |
| Ms. Nicole Jane Telford | Chief Financial Officer | -- | -- | -- |
| Mr. Alex McHenry | Chief Operating Officer | -- | -- | -- |
| Prof. Ming Hao Zheng | Chief Scientific Officer and Member of Medical & Scientific Advisory Board | -- | -- | -- |
| Mr. Tony Macintyre | Chief Technical Operations Officer | -- | -- | -- |
| Mr. Peter Gordon Webse B.Bus, FCIS, FCPA, FGIA, M.A.I.C.D. | Company Secretary | -- | -- | 1963 |
Orthocell Limited
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia. The company offers CelGro, a naturally derived collagen medical device for use in multiple indications to augment the surgical repair of bone, peripheral nerves, tendons, and cartilage; and Ortho-ATI, a cell therapy for treatment of chronic tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation to treat articular cartilage defects in the knee and ankle; Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental procedure; and Remplir, a collagen scaffold used in peripheral nerve repair. Orthocell Limited was incorporated in 2006 and is headquartered in Murdoch, Australia.
Corporate Governance
Recent Events
Recent Events Information Not Available